Table 1.

Demographics and clinical characteristics of participants with autosomal dominant polycystic kidney disease and control participants

VariableADPKD, n=61Control, n=19
Age, yra34±930±5
Sex, % men4658
Race/ethnicity, % non-Hispanic white8274
BMI, kg/m227.0±4.825.9±5.1
Systolic BP, mm Hga120±12114±12
Diastolic BP, mm Hga78±1069±6
CKD-EPI eGFR, ml/min per 1.73 m294±21104±16
LDL cholesterol, mg/dl96±2884±17
HDL cholesterol, mg/dl50±1357±15
Total cholesterol, mg/dl165±33155±20
Hypertension, %a1000
ACEi/ARB, %a1000
Diuretic, %a210
Calcium channel blockers, %70
Statin, %a210
Antidepressant or antianxiety medication, %1511
Thyroid medication, %75
  • Data are mean±SD or n (%). ADPKD, autosomal dominant polycystic kidney disease; BMI, body mass index; CKD-EPI; Chronic Kidney Disease Epidemiology Collaboration equation; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker.

  • a P<0.05 by chi-squared test or Fisher exact test for categorical data and independent sample t test for continuous variables.